• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬血液中通过双重过滤血浆置换选择性去除血浆蛋白:一项体外研究及三只犬体内临床治疗的回顾性报告

Selective Removal of Plasma Proteins by Double-Filtration Plasmapheresis in Canine Blood: An Ex Vivo Study and Retrospective Report of In Vivo Clinical Treatments in Three Dogs.

作者信息

Troia Roberta, Iannucci Claudia, Niemann Lisa, Vigani Alessio

机构信息

Section of Small Animal Emergency and Critical Care, Department of Small Animals, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.

出版信息

Vet Sci. 2025 May 29;12(6):528. doi: 10.3390/vetsci12060528.

DOI:10.3390/vetsci12060528
PMID:40559765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197782/
Abstract

Double-filtration plasmapheresis (DFPP) is a plasma-exchange modality that allows selective clearance of high-molecular-weight proteins, potentially minimizing albumin loss and the need for volume replacement. Reports concerning DFPP use in dogs are scarce. This study evaluates the quantitative net loss of different plasma proteins fractions in an ex vivo model using canine blood processed via DFPP. DFPP treatment with INUSpheresis processing 1.5, 2, and 3 plasma volumes (PVs) was performed. Plasma proteins fractions were measured in the reservoir blood bag at baseline (pre-treatment) and in the effluent bag at the end of each target PV exchanged to calculate the net loss of selected plasma proteins. At 1.5 PV, net globulin and albumin loss was 41 and 25% respectively. At 3 PV, net globulin and albumin loss was 47 and 40%, respectively. Fibrinogen concentration was unmeasurable low in the reservoir blood bag after processing 1.5 PV. INUSpheresis allows selective plasma proteins removal, with a sparing effect on albumin at 1.5 PV. Selectivity is, however, progressively reduced with incremental target PV. A description of five DFPP treatments in three dogs is additionally presented. Semi-selective protein removal was also demonstrated in vivo, with a significantly lower percentage reduction in albumin compared to total globulin ( = 0.01) and fibrinogen ( = 0.007).

摘要

双重过滤血浆置换术(DFPP)是一种血浆置换方式,可选择性清除高分子量蛋白质,可能会将白蛋白损失和容量置换需求降至最低。关于DFPP在犬类中的应用报道较少。本研究在一个体外模型中,使用通过DFPP处理的犬类血液,评估不同血浆蛋白组分的定量净损失。采用INUSpheresis处理1.5、2和3个血浆量(PV)进行DFPP治疗。在基线(治疗前)时测量储血袋中的血浆蛋白组分,并在每个目标PV置换结束时测量流出袋中的血浆蛋白组分,以计算选定血浆蛋白的净损失。在1.5 PV时,球蛋白和白蛋白的净损失分别为41%和25%。在3 PV时,球蛋白和白蛋白的净损失分别为47%和40%。在处理1.5 PV后,储血袋中的纤维蛋白原浓度低至无法测量。INUSpheresis可选择性去除血浆蛋白,在1.5 PV时对白蛋白有保留作用。然而,随着目标PV的增加,选择性逐渐降低。此外还介绍了对三只犬进行五次DFPP治疗的情况。体内也证明了半选择性蛋白质清除,与总球蛋白(P = 0.01)和纤维蛋白原(P = 0.007)相比,白蛋白的降低百分比显著更低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/1fca0b3f7be2/vetsci-12-00528-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/4b8eb13790fe/vetsci-12-00528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/0526614cea85/vetsci-12-00528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/1fca0b3f7be2/vetsci-12-00528-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/4b8eb13790fe/vetsci-12-00528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/0526614cea85/vetsci-12-00528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0f8/12197782/1fca0b3f7be2/vetsci-12-00528-g003.jpg

相似文献

1
Selective Removal of Plasma Proteins by Double-Filtration Plasmapheresis in Canine Blood: An Ex Vivo Study and Retrospective Report of In Vivo Clinical Treatments in Three Dogs.犬血液中通过双重过滤血浆置换选择性去除血浆蛋白:一项体外研究及三只犬体内临床治疗的回顾性报告
Vet Sci. 2025 May 29;12(6):528. doi: 10.3390/vetsci12060528.
2
Volume expanders for the prevention of ovarian hyperstimulation syndrome.用于预防卵巢过度刺激综合征的扩容剂。
Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001302. doi: 10.1002/14651858.CD001302.pub3.
3
Plasma exchange for Guillain-Barré syndrome.用于吉兰-巴雷综合征的血浆置换
Cochrane Database Syst Rev. 2002(2):CD001798. doi: 10.1002/14651858.CD001798.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Interventions for preventing weight gain after smoking cessation.戒烟后预防体重增加的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3.
7
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
8
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
9
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
10
Epidural therapy for the treatment of severe pre-eclampsia in non labouring women.硬膜外治疗非分娩期妇女的重度子痫前期。
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD009540. doi: 10.1002/14651858.CD009540.pub2.

本文引用的文献

1
The effects of double-filtration plasmapheresis on coagulation profiles and the risk of bleeding.双重滤过血浆置换对凝血谱和出血风险的影响。
J Formos Med Assoc. 2024 Aug;123(8):899-903. doi: 10.1016/j.jfma.2024.02.006. Epub 2024 Feb 23.
2
Changes in Water Properties in Human Tissue after Double Filtration Plasmapheresis-A Case Study.双滤过血浆置换后人组织中水分性质的变化——病例研究。
Molecules. 2022 Jun 20;27(12):3947. doi: 10.3390/molecules27123947.
3
Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis.
Horm Metab Res. 2022 Apr;54(4):238-249. doi: 10.1055/a-1776-7943. Epub 2022 Apr 12.
4
Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.三种血浆置换模式对凝血的比较:离心式、单膜过滤式和双膜过滤式血浆置换。
J Clin Apher. 2021 Jun;36(3):408-419. doi: 10.1002/jca.21879. Epub 2021 Jan 28.
5
Double filtration plasmapheresis: Review of current clinical applications.双重滤过血浆置换:当前临床应用综述。
Ther Apher Dial. 2021 Apr;25(2):145-151. doi: 10.1111/1744-9987.13548. Epub 2020 Aug 6.
6
Double filtration plasmapheresis in the treatment of hyperproteinemia in dogs affected by .双重过滤血浆置换术治疗患……的犬的高蛋白血症
J Vet Sci. 2018 May 31;19(3):472-476. doi: 10.4142/jvs.2018.19.3.472.
7
Effect of Double Filtration Plasmapheresis on Various Plasma Components and Patient Safety: A Prospective Observational Cohort Study.双重滤过血浆置换对各种血浆成分及患者安全性的影响:一项前瞻性观察性队列研究。
Indian J Nephrol. 2017 Sep-Oct;27(5):377-383. doi: 10.4103/ijn.IJN_64_17.
8
Plasmapheresis and other extracorporeal filtration techniques in critical patients.危重症患者的血浆置换及其他体外过滤技术
Med Intensiva. 2017 Apr;41(3):174-187. doi: 10.1016/j.medin.2016.10.005. Epub 2017 Jan 3.
9
Double filtration plasmapheresis in a dog with multiple myeloma and hyperviscosity syndrome.一只患有多发性骨髓瘤和高粘滞综合征的犬的双重滤过血浆置换术。
Open Vet J. 2015;5(2):108-12. Epub 2015 Aug 7.
10
Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis.
J Clin Apher. 2003;18(2):67-70. doi: 10.1002/jca.10052.